Alliqua BioMedical Inc (ALQA)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Alliqua BioMedical Inc (ALQA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011376
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s product categories include ultrasound healing therapy, human biologics, antimicrobial protection, and hydration. Its contract manufacturing business unit provides custom hydrogels to the OEM market. Alliqua BioMedical develops and manufactures electron-beam cross-linked sheet gels for manufacturer of medical devices, cosmeceuticals, and other commercial product applications. The company’s customer service professionals assist with order placement, product training, and reimbursement. Alliqua BioMedical is headquartered in Yardley, Pennsylvania, the US.

Alliqua BioMedical Inc (ALQA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Alliqua BioMedical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Alliqua BioMedical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Alliqua BioMedical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Alliqua BioMedical Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Alliqua BioMedical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Alliqua BioMedical Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Choice Therapeutics Secures US$0.6 Million In Financing 12
Partnerships 13
BSN medical to Enter into Distribution Agreement with Alliqua BioMedical 13
Alliqua Enters Into Distribution Agreement With Sorbion 14
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 15
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 16
Alliqua Enters Into Licensing Agreement With Noble Biomaterials 17
Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 18
Equity Offering 19
Alliqua BioMedical Raises USD3.8 Million in Public Offering of Shares 19
Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 21
Alliqua BioMedical Completes Public Offering of Shares for USD34.5 Million 22
Alliqua Completes Private Placement Of Shares For US$15 Million 24
Alliqua Completes Private Placement Of Shares For US$5.3 Million Upon Exercise Of Warrants 25
Alliqua Completes Private Placement Of Shares For US$6 Million 26
Alliqua Completes Private Placement Of Units For US$1 Million 28
Alliqua Completes Final Tranche Of Private Placement Of Shares For US$2 Million 29
Alliqua Completes Private Placement Of Shares For US$0.8 Million 30
Alliqua Completes Private Placement Of Units For US$0.3 Million 31
Alliqua Completes Private Placement Of Units For US$1.7 Million 32
Alliqua Completes Private Placement Of US$1 Million 33
Alliqua Completes Private Placement Of Shares For US$0.4 Million 34
Asset Transactions 35
Argentum Medical Acquires TheraBond and TheraBond 3D Antimicrobial Barrier Systems from Alliqua BioMedical for USD3.8 Million 35
Acquisition 36
Alliqua BioMedical Acquires Celleration for USD46.3 Million 36
Alliqua BioMedical Inc – Key Competitors 37
Alliqua BioMedical Inc – Key Employees 38
Alliqua BioMedical Inc – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Financial Announcements 40
Nov 09, 2017: Alliqua BioMedical Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook 40
Aug 10, 2017: Alliqua BioMedical Reports Second Quarter of Fiscal Year 2017 Financial Results 43
May 09, 2017: Alliqua BioMedical Reports First Quarter of Fiscal Year 2017 Financial Results 45
Apr 06, 2017: Alliqua BioMedical Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017 Outlook 46
Mar 07, 2017: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2016 Financial Results 47
Nov 04, 2016: Alliqua BioMedical Reports Third Quarter and Nine-Months Fiscal Year 2016 Financial Results 50
Oct 05, 2016: Alliqua BioMedical Announces Preliminary Third Quarter of Fiscal Year 2016 Revenue 52
Oct 05, 2016: Alliqua BioMedical Announces Preliminary Third Quarter of Fiscal Year 2016 Revenue; Earnings Conference Call Scheduled for November 4th 53
Aug 09, 2016: Alliqua BioMedical Reports Second Quarter and Six Months Fiscal Year 2016 Financial Results 54
Jul 07, 2016: Alliqua BioMedical Announces Preliminary Second Quarter of Fiscal Year 2016 Revenue 56
May 10, 2016: Alliqua BioMedical Reports First Quarter Financial Results 57
Feb 23, 2016: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2015 Financial Results 59
Corporate Communications 61
Feb 19, 2016: Alliqua BioMedical Announces Changes to Its Board of Directors 61
Other Significant Developments 62
Nov 09, 2017: Alliqua BioMedical Engages Cowen to Assist in Evaluating Potential Strategic Alternatives 62
Sep 05, 2017: Alliqua BioMedical Announces the Sale of TheraBond 3D Antimicrobial Barrier Systems Product Line; Alliqua Updates Fiscal Year Outlook 63
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65

List of Tables
Alliqua BioMedical Inc, Medical Equipment, Key Facts, 2016 2
Alliqua BioMedical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Alliqua BioMedical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Alliqua BioMedical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Alliqua BioMedical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Alliqua BioMedical Inc, Deals By Market, 2011 to YTD 2017 9
Alliqua BioMedical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Choice Therapeutics Secures US$0.6 Million In Financing 12
BSN medical to Enter into Distribution Agreement with Alliqua BioMedical 13
Alliqua Enters Into Distribution Agreement With Sorbion 14
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 15
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 16
Alliqua Enters Into Licensing Agreement With Noble Biomaterials 17
Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 18
Alliqua BioMedical Raises USD3.8 Million in Public Offering of Shares 19
Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 21
Alliqua BioMedical Completes Public Offering of Shares for USD34.5 Million 22
Alliqua Completes Private Placement Of Shares For US$15 Million 24
Alliqua Completes Private Placement Of Shares For US$5.3 Million Upon Exercise Of Warrants 25
Alliqua Completes Private Placement Of Shares For US$6 Million 26
Alliqua Completes Private Placement Of Units For US$1 Million 28
Alliqua Completes Final Tranche Of Private Placement Of Shares For US$2 Million 29
Alliqua Completes Private Placement Of Shares For US$0.8 Million 30
Alliqua Completes Private Placement Of Units For US$0.3 Million 31
Alliqua Completes Private Placement Of Units For US$1.7 Million 32
Alliqua Completes Private Placement Of US$1 Million 33
Alliqua Completes Private Placement Of Shares For US$0.4 Million 34
Argentum Medical Acquires TheraBond and TheraBond 3D Antimicrobial Barrier Systems from Alliqua BioMedical for USD3.8 Million 35
Alliqua BioMedical Acquires Celleration for USD46.3 Million 36
Alliqua BioMedical Inc, Key Competitors 37
Alliqua BioMedical Inc, Key Employees 38
Alliqua BioMedical Inc, Subsidiaries 39

★海外企業調査レポート[Alliqua BioMedical Inc (ALQA)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Norinchukin Bank:企業の戦略・SWOT・財務分析
    The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report Summary The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Liebherr-International AG:企業の戦略・SWOT・財務分析
    Liebherr-International AG - Strategy, SWOT and Corporate Finance Report Summary Liebherr-International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Clinova Ltd:企業の戦略的SWOT分析
    Clinova Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • SuperSonic Imagine SA (SSI):企業の財務・戦略的SWOT分析
    Summary SuperSonic Imagine SA (SuperSonic) is a medical device company that develops and supplies ultrasound medical imaging systems for measuring and visualizing tissue elasticity. The company offers ultrasound system, aixplorer that finds clinical applications in breast, abdomen, liver, vascular, …
  • Medical Prognosis Institute AS (MPI):医療機器:M&Aディール及び事業提携情報
    Summary Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers drug response prediction platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue …
  • Aethlon Medical Inc (AEMD):医療機器:M&Aディール及び事業提携情報
    Summary Aethlon Medical Inc (Aethlon Medical) is a developer of therapeutic technologies that address unmet needs in biodefense and global health. It develops immunotherapeutic technologies for the treatment of cancer and infectious diseases. The company’s lead product, Hemopurifier, strengthens nat …
  • Subex Ltd (SUBEX):企業の財務・戦略的SWOT分析
    Subex Ltd (SUBEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Lear Corporation:企業の戦略・SWOT・財務分析
    Lear Corporation - Strategy, SWOT and Corporate Finance Report Summary Lear Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Biofrontera AG (B8F):企業の財務・戦略的SWOT分析
    Biofrontera AG (B8F) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nordic Nanovector ASA (NANO):企業の財務・戦略的SWOT分析
    Summary Nordic Nanovector ASA (Nordic Nanovector), formerly Nordic Nanovector AS is a developer and commercializer of antibody radionuclide conjugates for the treatment of hematological cancers. The company’s lead product candidate includes Betalutin, an antibody radionuclide conjugate developed for …
  • ORBCOMM Inc (ORBC):企業の財務・戦略的SWOT分析
    ORBCOMM Inc (ORBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • American Outdoor Brands Corp:企業の戦略・SWOT・財務情報
    American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report Summary American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Galardi Group, Inc.:企業の戦略・SWOT・財務情報
    Galardi Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Galardi Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Restalia Grupo de Eurorestauracion SL:企業の戦略・SWOT・財務分析
    Restalia Grupo de Eurorestauracion SL - Strategy, SWOT and Corporate Finance Report Summary Restalia Grupo de Eurorestauracion SL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Cellnovo Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cellnovo Ltd (Cellnovo), formerly Starbridge Systems Ltd is a provider of conventional diabetes care technology solutions. The company offers mobile diabetes management systems such as insulin patch pump, cellular-enabled wireless touchscreen handset with integrated blood glucose meter, acti …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • AbbVie Inc (ABBV):企業の財務・戦略的SWOT分析
    AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Nila Infrastructures Ltd:企業の戦略・SWOT・財務分析
    Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • RayBiotech Inc-製薬・医療分野:企業M&A・提携分析
    Summary RayBiotech Inc (RayBiotech) is a life science company that offers proteins, antibodies and immunological kits. The company’s products include antibody arrays, elisa, functional assays, antibodies and custom recombinant protein service. It provides services such as testing services, custom se …
  • NovoCure Ltd (NVCR):企業の財務・戦略的SWOT分析
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆